Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2021 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
Rybarczyk-Kasiuchnicz A, Ramlau R, Stencel K. Rybarczyk-Kasiuchnicz A, et al. Among authors: stencel k. Int J Mol Sci. 2021 Jan 8;22(2):593. doi: 10.3390/ijms22020593. Int J Mol Sci. 2021. PMID: 33435596 Free PMC article. Review.
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.
Knetki-Wróblewska M, Dziadziuszko R, Jankowski T, Krawczyk P, Bryl M, Stencel K, Wrona A, Bandura A, Smok-Kalwat J, Rok-Knapińska J, Szydziak-Zwierzyńska K, Rogoziewicz K, Czyżewicz G, Wójtowicz M, Wojtukiewicz M, Kalinka E, Wysocki PJ, Łobacz M, Milanowski J, Pawlik H, Kowalski DM, Krzakowski M. Knetki-Wróblewska M, et al. Among authors: stencel k. Front Oncol. 2024 Jan 23;14:1341084. doi: 10.3389/fonc.2024.1341084. eCollection 2024. Front Oncol. 2024. PMID: 38322415 Free PMC article.
Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma.
Grenda A, Krawczyk P, Kucharczyk T, Błach J, Reszka K, Chmielewska I, Buczkowski J, Kieszko R, Siwiec J, Kubiatowski T, Bożyk A, Krukowska K, Jarosz B, Paśnik I, Pankowski J, Świniuch D, Stencel K, Gil M, Lew K, Ramlau R, Szczęsna A, Fidler S, Sieracki A, Każarnowicz A, Serwatowski P, Grodzki T, Milanowski J. Grenda A, et al. Among authors: stencel k. Oncol Lett. 2021 Jun;21(6):449. doi: 10.3892/ol.2021.12710. Epub 2021 Apr 7. Oncol Lett. 2021. PMID: 33868487 Free PMC article.
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.
Krawczyk P, Kowalski DM, Ramlau R, Kalinka-Warzocha E, Winiarczyk K, Stencel K, Powrózek T, Reszka K, Wojas-Krawczyk K, Bryl M, Wójcik-Superczyńska M, Głogowski M, Barinow-Wojewódzki A, Milanowski J, Krzakowski M. Krawczyk P, et al. Among authors: stencel k. Oncol Lett. 2017 Jun;13(6):4433-4444. doi: 10.3892/ol.2017.5980. Epub 2017 Apr 3. Oncol Lett. 2017. PMID: 28599445 Free PMC article.
11 results